Phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin’s lymphoma (NHL): Southwest Oncology Group Study S0108 Clinical characteristics of patients with chronic ...

Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process. Lori A. Leslie, MD: Hello, and welcome to CURE Expert Connections® ...

Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults in the western world, presenting at a median age of 65 years. 1 The diagnosis is often made incidentally during routine ...

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, typically developing slowly over time. Early symptoms may include painless lumps or swelling under the skin, weakness, ...

The FINANCIAL — Pharmacyclics, Inc. (Nasdaq: PCYC) on December 5 announced data from three Chronic Lymphocytic Leukemia (CLL) presentations at the American Society of Hematology (ASH) Annual Meeting ...

Investor & Analyst Virtual Event to Discuss Phase 1 U2 + Venetoclax Data to be held Monday, September 20, 2021 at 8:30 AM ET NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: ...

Andrew G. Lee, MD, and Drew Carey, MD, highlight how chronic lymphocytic leukemia can mimic Graves’ orbitopathy, underscoring the importance of a thorough evaluation.

If you have chronic lymphocytic leukemia (CLL), it's possible that your cancer will come back. The medical term for this is "relapse," and it means your disease returns or grows after you've been ...

NORTH CHICAGO, Ill., Dec. 10, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new and updated data across clinical and real-world studies in chronic lymphocytic leukemia (CLL). Presentations ...

SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, ...